Rafael de la Camara

- Head of Haematology

Hospital Universitario Virgen del Rocío

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

ORCID

Google Scholar

Academic Page

About

Rafael de la Camara is the Head of Haematology at Hospital Universitario de la Zarzuela in Spain. His research primarily focuses on infectious diseases related to hematopoietic cell transplantation and cellular therapies, as evidenced by his recent publications on topics such as post-transplant infections, pneumonia definitions, and management of cytomegalovirus. De la Camara actively contributes to the Infectious Disease Working Party of the European Society for Blood and Marrow Transplantation (EBMT), emphasizing clinical outcomes and guidelines in his field.

Rafael de la Camara

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Clinical characteristic and outcome of HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A study of Infectious Disease Working Party of EBMT

Pneumonia definition in allogeneic hematopoietic cell transplant recipients: Update and challenges in 2024. Recommendations from the EBMT Infectious Diseases Working Party and Practice Harmonization and Guidelines committee

Post-pandemic recommendations for the management of COVID-19 in patients with haematological malignancies or undergoing cellular therapy, from the European Conference on Infections in Leukaemia (ECIL-10)

Progressive Multifocal Leukoencephalopathy (PML) after hematopoietic cell transplantation (HCT): a retrospective study of Infectious Diseases Working Party (IDWP) of the EBMT

Recommendations from the 10th European Conference on Infections in Leukaemia for the management of cytomegalovirus in patients after allogeneic haematopoietic cell transplantation and otherT-cell-engaging therapies

Tuberculosis after hematopoietic cell transplantation: retrospective study on behalf of the infectious diseases working party of the EBMT

Prevalence, management, and new treatment modalities of EBV-DNA-emia and EBV-PTLD after allo-HCT: survey of Infectious Diseases Working Party EBMT

Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT

Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients

<i>Listeria monocytogenes</i> Infections in Hematopoietic Cell Transplantation Recipients: Clinical Manifestations and Risk Factors. A Multinational Retrospective Case-Control Study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation

Adenovirus infections after allogeneic hematopoietic cell transplantation in children and adults: a study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation

Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9)

Influence of invasive aspergillosis during acute leukaemia treatment on survival after allogeneic stem cell transplantation: a prospective study of the EBMT Infectious Diseases Working Party.

Pneumocystis Pneumonia After Allogeneic Hematopoietic Cell Transplantation: A Case-Control Study on Epidemiology and Risk Factors on Behalf of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.

Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients.

Occurrence of SARS-CoV-2 viremia is associated with genetic variants of genes related to COVID-19 pathogenesis.

SARS-CoV-2 vaccination in 361 non-transplanted patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria.

Upper and/or lower respiratory tract infection caused by human metapneumovirus after allogeneic hematopoietic stem cell transplantation.

Collaborators (7)

Per Ljungman

Elena Fernández-Ruiz

Stephan Mielke

Hans H. Hirsch

Jennifer Tjon

Jan Styczyński

Mette D. Hazenberg

How do I reach out?

Meet Kite AI